(Q36636721)

15 August 2017

1 reference

title

Perioperative considerations for patients treated with bleomycin (English)

1 reference

15 August 2017

Perioperative Considerations for Patients Treated with Bleomycin (English)

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

4 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1706974

Cardiology and cardiovascular medicine

4 November 2022

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

4 November 2022

author name string

Waid-Jones MI

1

1 reference

15 August 2017

M. I. Waid-Jones

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1706974

4 November 2022

D. B. Coursin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1706974

4 November 2022

language of work or name

English

0 references

publication date

1 April 1991

1 reference

full work available at URL

15 August 2017

https://api.elsevier.com/content/article/PII:S0012369216487659?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

https://api.elsevier.com/content/article/PII:S0012369216487659?httpAccept=text/plain

4 November 2022

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

4 November 2022

1 reference

15 August 2017

volume

99

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

993-999

1 reference

Bleomycin pulmonary toxicity

15 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

A clinical review of bleomycin--a new antineoplastic agent

4 November 2022

2

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Bleomycin causes alveolar macrophages from cigarette smokers to release hydrogen peroxide

4 November 2022

6

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Pulmonary toxicity of antineoplastic agents: Anaesthetic and postoperative implications

4 November 2022

7

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Factors influencing postoperative morbidity and mortality in patients treated with bleomycin.

4 November 2022

8

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Complications of retroperitoneal lymph node dissection

4 November 2022

9

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Risk Factors of Anesthesia and Surgery in Bleomycin-Treated Patients

4 November 2022

10

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Management of testicular seminoma

4 November 2022

13

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

4 November 2022

Neoplasms of the testis

14

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Mechanism of action of bleomycin. Studies with the growing culture of bacterial and tumor cells

4 November 2022

15

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Clinical pharmacology of bleomycin

4 November 2022

16

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats

4 November 2022

17

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Unraveling pulmonary fibrosis: the bleomycin model

4 November 2022

18

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Alterations in pulmonary protective enzymes following systemic bleomycin treatment in mice

4 November 2022

20

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Large-dose bleomycin therapy and pulmonary toxicity. A possible role of prior radiotherapy

4 November 2022

25

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Pulmonary toxicity of bleomycin

4 November 2022

28

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Relationship between Pulmonary Function Tests and Morphologic Changes in the Lung in Bleomycin-Treated Patients

4 November 2022

31

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Correlation of changes in pulmonary surfactant phospholipids with compliance in bleomycin-induced pulmonary fibrosis in the rat

4 November 2022

32

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Interstitial pneumonitis associated with bleomycin therapy.

4 November 2022

33

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Surfactant alterations following acute bleomycin and hyperoxia-induced lung damage

4 November 2022

34

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Pulmonary complications after bleomycin, irradiation and surgery for esophageal cancer

4 November 2022

39

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Enhanced bleomycin toxicity during acute renal failure

4 November 2022

42

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Fatal pulmonary bleomycin toxicity in cisplatin-induced acute renal failure

4 November 2022

43

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Factors Affecting the Pulmonary Toxicity of Bleomycin

4 November 2022

44

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Enhanced pulmonary toxicity in smokers with germ-cell cancer treated with cis-platinum, vinblastine and bleomycin: a long-term follow-up.

4 November 2022

45

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

The effect of bleomycin and oxygen on rat lung

4 November 2022

46

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Potentiation of bleomycin toxicity by oxygen

4 November 2022

47

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Exacerbation of tallysomycin toxicity in rats by concurrent exposure to sublethal hyperoxia

4 November 2022

48

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Non-lethal hyperoxic potentiation of lung disease in the rat following subcutaneous administration of bleomycin

4 November 2022

49

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Pulmonary toxicity after treatment with bleomycin alone or in combination with hyperoxia. Studies in the rat

4 November 2022

50

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Bleomycin hydrolase activity in pulmonary cells

4 November 2022

51

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice

4 November 2022

52

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Bleomycin therapy and anaesthesia. The possible hazards of oxygen administration to patients after treatment with bleomycin.

4 November 2022

53

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Bleomycin and subsequent anaesthesia: A retrospective study at Vancouver General Hospital

4 November 2022

54

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

Supplemental Oxygen Does Not Cause Respiratory Failure in Bleomycin-treated Surgical Patients

4 November 2022

55

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.4.993

4 November 2022

Identifiers

1 reference

15 August 2017

1 reference